CAPITAL FUND MANAGEMENT S.A. - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 342 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.2%.

Quarter-by-quarter ownership
CAPITAL FUND MANAGEMENT S.A. ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$1,126,498,000
-59.8%
15,028
-58.1%
0.01%
-56.5%
Q1 2022$2,803,179,000
+78.8%
35,883
+106.1%
0.02%
+109.1%
Q4 2021$1,567,950,000
+161377.9%
17,412
+75.5%
0.01%
-26.7%
Q1 2020$971,000
-71.0%
9,923
-61.8%
0.02%
-42.3%
Q4 2019$3,348,000
+229.2%
25,944
+92.2%
0.03%
+188.9%
Q3 2019$1,017,000
-68.0%
13,500
-35.4%
0.01%
-69.0%
Q2 2019$3,176,000
+73.9%
20,905
+36.4%
0.03%
+81.2%
Q1 2019$1,826,000
-74.1%
15,322
-76.2%
0.02%
-74.2%
Q4 2018$7,039,000
-51.6%
64,500
-28.3%
0.06%
-22.5%
Q3 2018$14,536,000
+76.7%
90,000
+44.6%
0.08%
+86.0%
Q2 2018$8,227,000
+195.3%
62,240
+65.5%
0.04%
+168.8%
Q1 2018$2,786,000
-36.7%
37,598
-52.4%
0.02%
-33.3%
Q4 2017$4,398,000
+418.6%
79,036
+322.7%
0.02%
+300.0%
Q3 2017$848,000
+57.3%
18,698
+16.9%
0.01%
+50.0%
Q2 2017$539,000
-93.8%
16,000
-94.5%
0.00%
-94.4%
Q1 2017$8,652,000
+295.6%
292,301
+415.6%
0.07%
+227.3%
Q4 2015$2,187,000
+62.2%
56,694
+35.0%
0.02%
+46.7%
Q3 2015$1,348,000
+311.0%
41,987
+69.8%
0.02%
+275.0%
Q1 2015$328,000
-43.4%
24,730
-9.9%
0.00%
-33.3%
Q3 2014$579,000
-92.3%
27,440
-92.6%
0.01%
-93.5%
Q4 2013$7,527,000
+38.7%
369,536
+221.6%
0.09%
+24.0%
Q3 2013$5,426,000114,8880.08%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Perceptive Advisors 2,878,979$69,182,0007.27%
Eventide Asset Management 259,100$6,226,0000.97%
GLADE BROOK CAPITAL PARTNERS LLC 251,000$6,032,0000.93%
IMS Capital Management 32,215$774,0000.91%
Perceptive Advisors 350,000$8,413,0000.88%
Benchmark Capital Advisors 34,900$839,0000.58%
BECK CAPITAL MANAGEMENT, LLC 24,744$636,0000.49%
SABBY MANAGEMENT, LLC 352,100$8,461,0000.47%
Hatteras Alternative Mutual Funds, LLC 39,404$947,0000.46%
Potomac Capital Management, Inc. 22,100$531,0000.45%
View complete list of SAREPTA THERAPEUTICS INC shareholders